LV12559B - Derivatives of 1,3,4-oxadiazolone - Google Patents

Derivatives of 1,3,4-oxadiazolone Download PDF

Info

Publication number: LV12559B
Authority: LV; Latvia
Prior art keywords: chloro; compound; oxadiazol; oxo; methyl
Prior art date: 1998-01-29

Application number

LVP-00-103A

Other languages

English (en)

Latvian (lv)

Other versions

LV12559A (en

Inventor

Piyasena Hewawasam

Min Ding

John E. Starrett Jr.

Original Assignee

Bristol-Myers Squibb Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-29

Filing date

2000-08-03

Publication date

2001-04-20

2000-08-03 Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company

2000-11-20 Publication of LV12559A publication Critical patent/LV12559A/xx

2001-04-20 Publication of LV12559B publication Critical patent/LV12559B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

LVP-00-103A 1998-01-29 2000-08-03 Derivatives of 1,3,4-oxadiazolone LV12559B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US7296698P	1998-01-29	1998-01-29
US10227498P	1998-09-29	1998-09-29
PCT/US1999/000910 WO1999038510A1 (fr)	1998-01-29	1999-01-15	Derives benzoate de 1,3,4-oxadiazolone

Publications (2)

Publication Number	Publication Date
LV12559A LV12559A (en)	2000-11-20
LV12559B true LV12559B (en)	2001-04-20

Family

ID=26753969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-00-103A LV12559B (en)	1998-01-29	2000-08-03	Derivatives of 1,3,4-oxadiazolone

Country Status (27)

Country	Link
US (1)	US6034113A (fr)
EP (1)	EP1051173A4 (fr)
JP (1)	JP2002527352A (fr)
KR (1)	KR20010077838A (fr)
CN (1)	CN1150175C (fr)
AR (1)	AR010712A1 (fr)
AU (1)	AU735704B2 (fr)
BG (1)	BG104706A (fr)
BR (1)	BR9913010A (fr)
CA (1)	CA2318830A1 (fr)
CO (1)	CO5090837A1 (fr)
EE (1)	EE04089B1 (fr)
GE (1)	GEP20032914B (fr)
HU (1)	HUP0102025A3 (fr)
ID (1)	ID26909A (fr)
IL (1)	IL137518A0 (fr)
LT (1)	LT4838B (fr)
LV (1)	LV12559B (fr)
NO (1)	NO317102B1 (fr)
NZ (1)	NZ505409A (fr)
PL (1)	PL342060A1 (fr)
RU (1)	RU2202548C2 (fr)
SK (1)	SK10852000A3 (fr)
TR (1)	TR200002019T2 (fr)
TW (1)	TW550075B (fr)
UA (1)	UA58579C2 (fr)
WO (1)	WO1999038510A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2319629A1 (fr) *	1998-01-29	1999-08-05	Bristol-Myers Squibb Company	Derives aminoacides de diaryl 1,3,4-oxadiazolone
KR20010101869A (ko) *	1999-01-29	2001-11-15	스티븐 비. 데이비스	디아릴 1,3,4-옥사디아졸론의 카바메이트 유도체
US6297241B1 (en)	1999-01-29	2001-10-02	Bristol-Myers Squibb Company	Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) *	1999-12-21	2001-12-04	Celgene Corporation	Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
JP2005507853A (ja)	2001-02-20	2005-03-24	ブリストル−マイヤーズ　スクイブ　カンパニー	Ｋｃｎｑカリウムチャンネルモジュレーター並びに片頭痛および機構的に関連する疾患の治療におけるそれらの使用
NZ529043A (en) *	2001-04-16	2006-11-30	Tanabe Seiyaku Co	Large conductance calcium-activated K channel opener
US6909027B1 (en) *	2001-08-13	2005-06-21	Perry Robins	Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) *	2002-06-25	2006-10-10	Perry Robins	Method of treating acne
CN104540504A (zh)	2012-01-18	2015-04-22	苏州泰飞尔医药有限公司	治疗肺部疾病的高穿透力前药组合物和医药组合物
JP5855599B2 (ja) *	2013-04-30	2016-02-09	テックフィールズバイオケムカンパニーリミテッド	非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) *	2015-03-09	2017-01-18	华南理工大学	一种bms‑191011的合成方法
JP6165816B2 (ja) *	2015-10-01	2017-07-19	テックフィールズバイオケムカンパニーリミテッド	非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
WO2018157046A1 (fr) *	2017-02-24	2018-08-30	Ovid Therapeutics Inc.	Méthodes de traitement de troubles épileptiques
WO2020086149A1 (fr)	2018-10-26	2020-04-30	University Of South Florida	Médicament pour le traitement de l'acouphène
CN110987847B (zh) *	2019-12-11	2021-02-19	苏州今蓝纳米科技有限公司	1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH583213A5 (fr) *	1973-05-21	1976-12-31	Ciba Geigy Ag
IT1251488B (it) *	1991-09-17	1995-05-15	Mini Ricerca Scient Tecnolog	Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) *	1991-11-07	1993-08-10	New York University	Potassium channel activating compounds and methods of use thereof
US5547966A (en) *	1993-10-07	1996-08-20	Bristol-Myers Squibb Company	Aryl urea and related compounds
TW467902B (en) *	1996-07-31	2001-12-11	Bristol Myers Squibb Co	Diphenyl heterocycles as potassium channel modulators
CA2319629A1 (fr) *	1998-01-29	1999-08-05	Bristol-Myers Squibb Company	Derives aminoacides de diaryl 1,3,4-oxadiazolone

1999
- 1999-01-15 US US09/232,033 patent/US6034113A/en not_active Expired - Fee Related
- 1999-01-15 GE GEAP19995472A patent/GEP20032914B/en unknown
- 1999-01-15 PL PL99342060A patent/PL342060A1/xx unknown
- 1999-01-15 CN CNB998024112A patent/CN1150175C/zh not_active Expired - Fee Related
- 1999-01-15 JP JP2000529243A patent/JP2002527352A/ja active Pending
- 1999-01-15 NZ NZ505409A patent/NZ505409A/en unknown
- 1999-01-15 WO PCT/US1999/000910 patent/WO1999038510A1/fr not_active Ceased
- 1999-01-15 RU RU2000122733/04A patent/RU2202548C2/ru not_active IP Right Cessation
- 1999-01-15 EE EEP200000447A patent/EE04089B1/xx not_active IP Right Cessation
- 1999-01-15 CA CA002318830A patent/CA2318830A1/fr not_active Abandoned
- 1999-01-15 KR KR1020007008227A patent/KR20010077838A/ko not_active Withdrawn
- 1999-01-15 ID IDW20001421A patent/ID26909A/id unknown
- 1999-01-15 HU HU0102025A patent/HUP0102025A3/hu unknown
- 1999-01-15 IL IL13751899A patent/IL137518A0/xx unknown
- 1999-01-15 BR BR9913010-6A patent/BR9913010A/pt not_active IP Right Cessation
- 1999-01-15 TR TR2000/02019T patent/TR200002019T2/xx unknown
- 1999-01-15 EP EP99902290A patent/EP1051173A4/fr not_active Withdrawn
- 1999-01-15 SK SK1085-2000A patent/SK10852000A3/sk unknown
- 1999-01-15 AU AU22308/99A patent/AU735704B2/en not_active Ceased
- 1999-01-15 UA UA2000085059A patent/UA58579C2/uk unknown
- 1999-01-27 TW TW088101231A patent/TW550075B/zh not_active IP Right Cessation
- 1999-01-27 AR ARP990100312A patent/AR010712A1/es not_active Application Discontinuation
- 1999-01-28 CO CO99004746A patent/CO5090837A1/es unknown
2000
- 2000-07-14 LT LT2000068A patent/LT4838B/lt not_active IP Right Cessation
- 2000-07-26 NO NO20003825A patent/NO317102B1/no not_active IP Right Cessation
- 2000-08-03 LV LVP-00-103A patent/LV12559B/en unknown
- 2000-08-22 BG BG104706A patent/BG104706A/xx unknown

Also Published As

Publication number	Publication date
NZ505409A (en)	2003-08-29
NO20003825D0 (no)	2000-07-26
TW550075B (en)	2003-09-01
UA58579C2 (uk)	2003-08-15
AU735704B2 (en)	2001-07-12
LT4838B (lt)	2001-08-27
US6034113A (en)	2000-03-07
BR9913010A (pt)	2001-05-08
LV12559A (en)	2000-11-20
PL342060A1 (en)	2001-05-21
ID26909A (id)	2001-02-15
RU2202548C2 (ru)	2003-04-20
LT2000068A (en)	2001-03-26
CO5090837A1 (es)	2001-10-30
KR20010077838A (ko)	2001-08-20
BG104706A (en)	2001-04-30
WO1999038510A1 (fr)	1999-08-05
NO20003825L (no)	2000-07-26
CN1150175C (zh)	2004-05-19
EP1051173A1 (fr)	2000-11-15
AU2230899A (en)	1999-08-16
GEP20032914B (en)	2003-03-25
IL137518A0 (en)	2001-07-24
SK10852000A3 (sk)	2002-02-05
NO317102B1 (no)	2004-08-09
TR200002019T2 (tr)	2000-11-21
EE200000447A (et)	2001-12-17
CA2318830A1 (fr)	1999-08-05
EP1051173A4 (fr)	2002-07-31
AR010712A1 (es)	2000-07-12
EE04089B1 (et)	2003-08-15
HUP0102025A2 (hu)	2001-11-28
CN1289249A (zh)	2001-03-28
JP2002527352A (ja)	2002-08-27
HUP0102025A3 (en)	2002-01-28

Publication	Publication Date	Title
US6034113A (en)	2000-03-07	Derivatives of 1,3,4-oxadiazolone
US5939405A (en)	1999-08-17	Phosphate derivatives of diaryl 1,3,4-oxadiazolone
US5948802A (en)	1999-09-07	Benzoate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en)	2000-12-19	Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US5977150A (en)	1999-11-02	Amino acid derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en)	2001-10-02	Carbamate derivatives of diaryl 1,3,4-oxadiazolone
CZ20002647A3 (cs)	2001-06-13	Deriváty 1,3,4-oxadiazolonu